Clinical Laboratory DX Exam 2 Practice

Elevated homocysteine signals a vascular and neurotoxic risk pathway that strongly links to stroke and cognitive decline, including dementia and Alzheimer’s disease. Homocysteine accumulates when it isn’t properly metabolized by the body, a process that depends on B vitamins (folate, B6, B12). Higher levels damage the endothelium, promote blood clotting, and increase oxidative stress, all of which raise stroke risk. In the brain, excess homocysteine can contribute to small-vessel disease and neuronal injury, promoting cognitive impairment and pathways involved in Alzheimer-type changes. That combination helps explain why elevated homocysteine is associated with a markedly increased risk for both vascular events and dementia. Lowering homocysteine through adequate B vitamin intake reduces its level, though how reliably this translates to reduced stroke risk in all populations has shown mixed results. The other options are less specific: C-reactive protein reflects general inflammation, LDL cholesterol relates to atherogenesis but not as directly to dementia risk, and high glucose is a metabolic risk factor with broader effects but not as tightly tied to Alzheimer’s disease mechanisms.